This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Christopher Hanson
Christopher Hanson
Washington +1 202 662 5977 Download V-card

Christopher Hanson advises international and domestic clients on U.S. regulatory strategies and compliance for medical devices, pharmaceuticals, biological products, cosmetics, and radiation-emitting electronic products. His broad range of clients include large multinational companies, venture capital firms, industry associations, clinical laboratories, and development-stage companies.

Mr. Hanson has extensive experience counseling clients on interactions with state and federal regulatory agencies, including the Food and Drug Administration (FDA), the Drug Enforcement Administration (DEA), the Federal Trade Commission (FTC), and the Centers for Medicare and Medicaid Services (CMS).

  • Provide FDA regulatory diligence to client for $575 million acquisition of a branded respiratory portfolio. 
  • Provide FDA regulatory diligence to client for $1.7 billion acquisition of a clinical-stage biopharmaceutical company.
  • Advise underwriters in $175 million follow-on public offering of common stock by molecular diagnostics company.
  • Represent top global pharmaceutical company in internal review of procedures and policies concerning investigator-initiated trials (IITs).
  • Represent client in internal review of procedures and policies concerning cosmetic product labeling.
  • Represent industry association in preparing FDA and IOM public comments responding to various draft guidance or study documents concerning clinical trial informed consent, electronic submission of data, clinical trial data sharing, and the use of the Internet/social media. 
  • Write white papers for clients on proposed legislation involving pharmaceutical and medical device regulation in foreign jurisdictions, including Canada and India.
  • Advise industry association regarding FDA regulatory aspects of 21st Century Cures Act.

Pro Bono

  • Represent Federally Qualified Health Center (FQHC) in preparing FDA public comments concerning agency blood donation guidelines.
  • Advise LGBT organization on legal issues and strategies involving transgender military service members.
  • Successfully represent Latin American immigrant in U visa application.
  • Represent LGBT organization in preparation for potential election referendum on state transgender rights law.
  • Advise transgender individuals on legal name and gender change procedures in Maryland, Virginia, and Washington, D.C.

Memberships and Affiliations

  • Harvard University, Divinity School Alumni/ae Board (Chairman, 2016-2017)   
  • Yale College, Class of 2005 Reunion Chair
  • Humanity-in-Action, Senior Fellow
  • Point Foundation, Wells Fargo Scholar and Mentorship Committee (former)

Previous Experience

  • United States Senate, Constituent Services (2008-2010)
  • Harvard University, Harvard Humanitarian Initiative Instructor (2008)
  • Yale University, Assistant Director of Undergraduate Admissions (2005-2007)